Business person contemplating how to navigate a maze made of money
Biotech

Why experts fear fallout from Treasury’s China biotech crackdown

Experts told Fierce of anxiety around how the COINS Act proposal treats the myriad deal structures that keep biopharma dealmaking flowing.
Angus Liu Nov 10, 2026 9:30am
akt health

Why scientific progress depends on knowing when to look again

Brought to you by Ipsen
Job cuts employee layoffs firings or downsizing Scissors dividing individuals positioned on colorful blocks

Coherus shrinks headcount 30% to narrow focus of cancer combo

Nov 10, 2026 3:52am
Advanced Analytics Help Reduce Control Animal Use While Preserving Scientific Rigor

How Virtual Control Groups Are Shaping Safety Studies

Brought to you by Charles River Laboratories
AbCellera high throughput lab robot

AbCellera becomes latest biotech to abandon OX40 drug

Nov 10, 2026 5:06am
AZ

AstraZeneca buys partner Omniose for bacterial vaccine tech

Nov 10, 2026 10:16am
More News

Beam’s sickle cell results signal Casgevy, Lyfgenia showdown

Nov 10, 2026 3:19pm

PepGen’s stock doubles as midphase DM1 data wow analysts

Nov 10, 2026 10:21am

Mirum scores again in hep D phase 3, setting up FDA run

Nov 10, 2026 10:00am

Fierce Biotech Fundraising Tracker '26: Oyster, Delix & more

Nov 10, 2026 10:00am